Processa Pharmaceuticals, Inc. (PCSA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2024-03-29; 1-for-25, first reflected in a filing dated 2026-03-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.31M
Year ended 2025-12-31
32.60M2016-12-31: 29.32M2017-12-31: 32.60M2022-12-31: 805.5K2023-12-31: 1.31M2024-12-31: 122.4K2025-12-31: 1.31M1.31M
2016-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-311.31M+969.3%2026-03-18, From 2025-01-01
2024-12-31122.4Kn/c2026-03-18, From 2024-01-01
2023-12-311.31M+62.8%2025-03-20, From 2023-01-01
2022-12-31805.5Kn/c2024-03-29, From 2022-01-01
No annual figure between 2017-12-31 and 2022-12-31.
2017-12-3132.60M+11.2%2018-04-16, From 2017-01-01
2016-12-3129.32Mn/a2018-04-16, From 2016-01-01